Logo image
Back
Post-anaphylaxis observation in the ED: a decade of data challenging the traditional 24-hour rule
Journal article - Review   Open access   Peer reviewed

Post-anaphylaxis observation in the ED: a decade of data challenging the traditional 24-hour rule

Khaled Abouelmagd, Joseph Alhaddad, Temitomi Jane Oyedele, Rufaida Riaz Ali, Ursula Abu Nahla, Lauren A. Carr and Mohammed Alsabri
International journal of emergency medicine, v 19(1), 63
14 Mar 2026
DOI: https://doi.org/10.1186/s12245-026-01175-4
PMID: 41832433
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1186/s12245-026-01175-4View
Published, Version of Record (VoR) Open CC BY-NC-ND V4.0

Abstract

Emergency Medicine Life Sciences & Biomedicine Science & Technology
Background Biphasic anaphylaxis remains an under-recognized threat who's timing directly conflicts with conventional 2-4-hour ED observation practices. Methods This narrative review synthesizes evidence published between 2015 and 2025, sourced from PubMed, MEDLINE, and major allergy/immunology society guidelines. A narrative synthesis was chosen due to heterogeneity in definitions and outcome reporting across studies. The analysis focuses on the evolution of risk factors, diagnostic criteria, and the performance of time-based observation strategies to inform contemporary ED disposition policies. Key Findings Over the past decade, a paradigm shift has occurred, moving away from fixed observation durations toward risk-stratified approaches. Major practice parameters from the American Academy of Allergy, Asthma, and Immunology (AAAAI) and the American College of Allergy, Asthma, and Immunology (ACAAI) now emphasize individualized observation based on the severity of the initial event. More than half of clinically significant biphasic events occur after four to six hours, indicating that traditional observation windows are insufficient for many patients. Key predictors of biphasic reactions consistently identified include a severe initial presentation (e.g., hypotension, hypoxia), the need for more than one dose of epinephrine, and a delay in initial epinephrine administration. Recent meta-analytic work has quantified the performance of observation cut-offs, demonstrating a pooled negative predictive value (NPV) of similar to 95% at 1 h, rising to similar to 97% at >= 6 h, and > 98% for observation periods exceeding 8-12 h. This suggests that observation periods under 6 h may be insufficient for many patients, aligning with UK National Institute for Health and Care Excellence (NICE) guidance, which typically recommends 6-12 h of observation, particularly when risk factors are present. Conclusion EDs should adopt risk-stratified observation pathways. A low-risk pathway (e.g., rapid and complete resolution after a single epinephrine dose, known food trigger, no cardiovascular or respiratory compromise) may permit shorter observation if coupled with a robust discharge education bundle. Conversely, a high-risk pathway (e.g., delayed or >= 2 epinephrine doses, hypotension/hypoxia, non-food/unknown trigger, or comorbidities like asthma or beta-blocker use) warrants prolonged observation (>= 6 h) or hospital admission. Future research should prioritize prospective, multicenter ED registries to precisely document the timing of treatment-requiring relapses and further refine the dose-response relationship between observation duration and the risk of missed biphasic events, stratified by age and trigger.

Metrics

1 Record Views

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Emergency Medicine
Logo image